Only Loestrin Market Matters In Antitrust Row, Retailers Say
Warner Chilcott can't avoid antitrust litigation over sales of its birth control medication Loestrin 24 by claiming it shares the market with all available oral birth control, as the allegations in...To view the full article, register now.
Already a subscriber? Click here to view full article